Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immunohistochemical expression of p16(INK4A) protein in oral lichen planus.
Montebugnoli L, Venturi M, Gissi DB, Leonardi E, Farnedi A, Foschini MP. Montebugnoli L, et al. Among authors: farnedi a. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011 Aug;112(2):222-7. doi: 10.1016/j.tripleo.2011.02.029. Epub 2011 May 25. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011. PMID: 21612953
IGFBP2 as an immunohistochemical marker for prostatic adenocarcinoma.
Ambrosini-Spaltro A, Farnedi A, Montironi R, Foschini MP. Ambrosini-Spaltro A, et al. Among authors: farnedi a. Appl Immunohistochem Mol Morphol. 2011 Jul;19(4):318-28. doi: 10.1097/PAI.0b013e3128052936. Appl Immunohistochem Mol Morphol. 2011. PMID: 21304397
Podoplanin and E-cadherin expression in preoperative incisional biopsies of oral squamous cell carcinoma is related to lymph node metastases.
Foschini MP, Leonardi E, Eusebi LH, Farnedi A, Poli T, Tarsitano A, Cocchi R, Marchetti C, Gentile L, Sesenna E, Marucci G, Montebugnoli L. Foschini MP, et al. Among authors: farnedi a. Int J Surg Pathol. 2013 Apr;21(2):133-41. doi: 10.1177/1066896912471851. Epub 2013 Jan 24. Int J Surg Pathol. 2013. PMID: 23349470
Proteoglycan-based diversification of disease outcome in head and neck cancer patients identifies NG2/CSPG4 and syndecan-2 as unique relapse and overall survival predicting factors.
Farnedi A, Rossi S, Bertani N, Gulli M, Silini EM, Mucignat MT, Poli T, Sesenna E, Lanfranco D, Montebugnoli L, Leonardi E, Marchetti C, Cocchi R, Ambrosini-Spaltro A, Foschini MP, Perris R. Farnedi A, et al. BMC Cancer. 2015 May 3;15:352. doi: 10.1186/s12885-015-1336-4. BMC Cancer. 2015. PMID: 25935541 Free PMC article.
33 results